Cardiva Catalyst II Vascular Access Management Device in Percutaneous Diagnostic and Interventional Procedures With Same-Day Discharge (CATALYST II Trial)

Abstract

Cardiva Catalyst is safe and effective device in achieving local hemostasis after percutaneous diagnostic procedures and interventions performed under bivalirudin anticoagulation. The use of this device with an appropriate protocol facilitates same-day discharge.

Feasibility, safety, and patient satisfaction of same‐day discharge following peripheral arterial interventions: A randomized controlled study

“…In accordance with the study's protocol, the OS group was monitored for 24‐hr events necessitating either (a) a return to the emergency room or (b) readmission to inpatient status. Based on an assumed population adverse event rate of 2% , the probability that ≥2 adverse events per 10 discharges occurs solely by chance is <0.05. Therefore, the trial would be stopped if two (2) adverse events occurred in the intervention prior to the 11th discharge; and if two adverse events occurred in the intervention group between the 11th and 20th discharges.…”

“…In accordance with the study's protocol, the OS group was monitored for 24-hr events necessitating either (a) a return to the emergency room or (b) readmission to inpatient status. Based on an assumed population adverse event rate of 2% [12,13], the probability that 2 adverse events per 10 discharges occurs solely by chance is <0.05.…”

Risk assessment in patients with ST elevation myocardial infarction treated with primary percutaneous coronary angioplasty. Does reduced duration of hospital stay affect the prognosis?

“…Some hospitals successfully apply same-day discharge hospitalisation protocols for patients electively treated with coronary or peripheral procedures [16][17][18]. In Poland, in 2001 newly-formed centres of the American Heart of Poland introduced a model of invasive procedures based on short-term hospital stays.…”

Commentary: Use of the 8-F Angio-Seal Vascular Closure Device for Much Larger Sheaths: Successfully Fitting a Square Peg Into a Round Hole?

“…2 Other vascular closure devices are available for smaller sheaths, such as St. Jude Medical's 6-F and 8-F Angio-Seal, Abbott Vascular's 6-F StarClose, and others, which collectively may have several advantages over suture-based devices. 3,4 Indeed, Angio-Seal probably represents the most commonly used vascular closure device, given its safety, non-invasiveness, ease of use, and versatility. 5,6 Accordingly, Angio-Seal has been deployed with satisfactory results after antegrade femoral puncture, as well as in axillary, brachial, carotid, superficial femoral, and popliteal arteries.…”